<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article article-type="research-article">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Br J Cancer</journal-id>
      <journal-id journal-id-type="iso-abbrev">Br. J. Cancer</journal-id>
      <journal-title-group>
        <journal-title>British Journal of Cancer</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0007-0920</issn>
      <issn pub-type="epub">1532-1827</issn>
      <publisher>
        <publisher-name>Nature Publishing Group</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">10070858</article-id>
      <article-id pub-id-type="pmc">2362677</article-id>
      <article-id pub-id-type="pii">6690114</article-id>
      <article-id pub-id-type="doi">10.1038/sj.bjc.6690114</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Regular Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Isolation and characterization of a new human breast cancer cell line, KPL-4, expressing the Erb B family receptors and interleukin-6</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Kurebayashi</surname>
            <given-names>J</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Otsuki</surname>
            <given-names>T</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kurosumi</surname>
            <given-names>M</given-names>
          </name>
          <xref ref-type="aff" rid="aff4">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Yamamoto</surname>
            <given-names>S</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Tanaka</surname>
            <given-names>K</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Mochizuki</surname>
            <given-names>M</given-names>
          </name>
          <xref ref-type="aff" rid="aff5">5</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Nakamura</surname>
            <given-names>H</given-names>
          </name>
          <xref ref-type="aff" rid="aff5">5</xref>
        </contrib>
        <aff id="aff1">Department of Breast and Thyroid Surgery, Kawasaki Medical School, Kurashiki, Okayama, 701-01, Japan</aff>
        <aff id="aff2">Department of Hygiene, Kawasaki Medical School, Kurashiki, Okayama, 701-01, Japan</aff>
        <aff id="aff3">Lombardi Cancer Center, Georgetown University Medical Center, Washington DC, 20007, USA</aff>
        <aff id="aff4">Department of Pathology, Saitama Cancer Center, Kitaadachi-gun, Saitama, 362, Japan</aff>
        <aff id="aff5">Yokohama Research Center, Mitsubishi Chemical Corporation, Aoba-ku, Yokohama, 227, Japan</aff>
      </contrib-group>
      <author-notes>
        <corresp id="caf1"><label>*</label>Department of Breast and Thyroid Surgery, Kawasaki Medical School, 577 Matsushima, Kurashiki, Okayama 701-0192, Japan</corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <month>2</month>
        <year>1999</year>
      </pub-date>
      <volume>79</volume>
      <issue>5-6</issue>
      <fpage>707</fpage>
      <lpage>717</lpage>
      <history>
        <date date-type="received">
          <day>24</day>
          <month>02</month>
          <year>1998</year>
        </date>
        <date date-type="rev-recd">
          <day>04</day>
          <month>08</month>
          <year>1998</year>
        </date>
        <date date-type="accepted">
          <day>05</day>
          <month>08</month>
          <year>1998</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright &#xA9; 1999 Cancer Research Campaign</copyright-statement>
        <copyright-year>1999</copyright-year>
        <copyright-holder>Cancer Research Campaign</copyright-holder>
      </permissions>
      <abstract>
        <p>A new human breast cancer cell line, KPL-4, was recently isolated from the malignant pleural effusion of a breast cancer patient with an inflammatory skin metastasis. This cell line can be cultured under serum-free conditions and is tumorigenic in female athymic nude mice. Flow cytometric analysis revealed the expression of Erb B-1, -2 and -3. Dot blot hybridization showed a 15-fold amplification of the <italic>erb</italic>B-2. Reverse transcription-polymerase chain reaction analysis showed a detectable level of mRNA expression of all the Erb B family receptors. In addition, all the receptors were autophosphorylated under a serum-supplemented condition. Unexpectedly, transplanted KPL-4 tumours induced cachexia of recipient mice. A high concentration of interleukin-6 (IL-6) was detected in both the culture medium and the serum of mice. The weight of tumours significantly correlated with the serum IL-6 level. The antiproliferative effect of a humanized anti-Erb B-2 monoclonal antibody, rhuMAbHER2, was investigated. This antibody significantly inhibited the growth of KPL-4 cells in vitro but modestly in vivo. Loss of mouse body weight was partly reversed by rhuMAbHER2. These findings suggest that KPL-4 cells may be useful in the development of new strategies against breast cancer overexpressing the Erb B family receptors and against IL-6-induced cachexia. &#xA9; 1999 Cancer Research Campaign</p>
      </abstract>
      <kwd-group>
        <kwd>breast cancer</kwd>
        <kwd>cell line</kwd>
        <kwd>Erb B-2</kwd>
        <kwd>cachexia</kwd>
        <kwd>interleukin-6</kwd>
      </kwd-group>
    </article-meta>
  </front>
</article>
</pmc-articleset>
